Inhibitors: Who Gets Them? Prevention and Management

Hemophilia Education Series
1 ACPE 1 ANCC Contact Hours 1 AMA PRA Category 1 Credit(s)
Launch Date:
July 29, 2015
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Physicians, Nurses, Pharmacists

Relevant Terms:


Chris Guelcher, MS, APRN, PPCNP-BC

Chris Guelcher, MS, APRN, PPCNP-BC
Pediatric Nurse Practitioner
Department of Hematology/Oncology
Children's National Medical Center
111 Michigan Avenue, NW
Washington, DC

Chris Guelcher is the Program Coordinator of the Hemostasis and Thrombosis Program at Children's National Healthy System (CNHS) since 1997) Chris received her Bachelors of Science in Nursing from Georgetown University and her Masters of Science with certification as a Pediatric Nurse Practitioner in 1997 from the University of Maryland. Prior to entering hemophilia care, Chris worked on an inpatient Hematology/Oncology unit at Children's Memorial Hospital in Chicago, Illinois and later at Mott Children's Hospital in Ann Arbor, Michigan. Prior to her appointment as Hemophilia Nurse Coordinator at CNMC in 1997, Chris worked on the inpatient unit and in the outpatient clinic as a Hematology/Oncology nurse at Children's National Healthy System where she has worked since 1992.
Chris is a past member of the National Hemophilia Foundation (NHF) Nursing Working Group for 3 years and is now serving for a second time on the Region III/Mid-Atlantic Regional Executive Committee. Chris continues to serve on the Board of the American Thrombosis and Hemostasis Network (ATHN) which she joined in 2009. She is the current Chair of the ATHN Community Relations and Communications Subcommittee. Chris was a member of the Hemophilia and Thrombosis Soecity (HTRS) program planning committee for the 2010 and 2011 annual meetings. Chris was then one of the nurse planners for the first meeting of the Thrombosis and Hemostasis Summit of North America (THSNA) in 2012. She has subsequently been participating on the steering committee of what recently became the Thrombosis and Hemostasis Societies of North America. She was recently appointed to be the nurse liaison to the THSNA Board of Directors.
Recognized as a long-standing member of the bleeding disorder healthcare provider community, Chris has presented nationally and internationally. She also has been a contributing author to numerous posters, abstracts and journal articles.
Chris helped develop and update hematology drug information sheets for parents as well as a hemophilia brochure for patients and families at the request of The Association of Pediatric Hematology and Oncology Nurses (APHON). She also serves on the Certification and Continuing Education Committee and the Programming Subcommittee of the American Society of Pediatric Hematology Oncology (ASPHO).

Sue Geraghty, RN MBA

Sue Geraghty, RN, MBA
Nurse Planner
SolutionSight Inc.
2191 Avalon Drive
Buffalo Grove, IL

Ms. Geraghty has an Associate of Arts degree in nursing from Lander College in 1977, a Bachelor of Science degree in Nursing in 1980 from University of North Carolina at Charlotte and a Masters in Business (MBA) from University of Colorado Denver in 1990. She worked as Nurse Coordinator at the University of Colorado Denver Hemophilia and Thrombosis Center for 25 years where she retired in2013. Currently she is working as an independent consultant in the areas of hemophilia and health care education. Prior to working at the HTC, Ms. Geraghty worked in orthopaedics where she was initially introduced to patients with hemophilia. She is certified as an Orthopaedic Nurse Clinician through the National Association of Orthopaedic Nurses where she is still an active member. During her time as nurse coordinator at the Hemophilia Treatment Center, she has sat on a number of national committees including the Nursing working Group for the National Hemophilia Foundation. She has spoken locally, nationally and internationally and has been published in many peer reviewed journals. Her areas of interest within the hemophilia community include the adult patient with bleeding disorders, patients with inhibitors and orthopaedic issues.
1. Define inhibitor diagnosis and complications in hemophilia.
2. Identify inhibitor risk factors and prevention strategies for hemophilic inhibitors.
3. Explain goal and use of inhibitor treatment therapeutics for hemophilic inhibitors.
4. Compare and contrast the similarities and differences of congenital and acquired inhibitors.

If you have questions about this CME activity, please contact AKH Inc. at or SolutionSight Inc. at
CME credit provided by AKH Inc., Advancing Knowledge in Healthcare.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and SolutionSight, Inc. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
CE credit provided by SolutionSight, Inc.

SolutionSight, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is awarded 1 contact hour.


SolutionSight, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Solutionsight Inc. approves this knowledge-based activity for 1 contact hour (0.1 CEUs).
UAN 0450-9999-15-004-H01-P. Initial Release Date: July 29, 2015.
Activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and SolutionSight, Inc.
Name Relationship Commercial Interest
Christine Guelcher MS, PNP-BC Consultant Baxter Healthcare Corporation;  BioSolutions Inc.; Novo Nordisk
  Speakers Bureau
Biogen Idec; Emergent BioSolutions Inc.; Novo Nordisk
Board of Directors ATHN, THSNA
SolutionSight, Inc. Staff and Planners N/A Nothing to disclose
AKH Inc. Staff and Planners N/A Nothing to disclose
Commercial Support
This activity is supported by an educational grant from Baxter Healthcare Corporation.
It is the policy of AKH Inc. and SolutionSight, Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review. 
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. and SolutionSight, Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8      
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above

For video playback, install the latest version of Flash or Quicktime.